The Association of Different Serum IgG4 Levels with Distinct Clinical Characteristics and Treatment Efficacy in Patients with IgG4-related Disease.

P. Zhang,Z. Liu,J. Li,Y. Fei,X. Wang,M. Wang,L. Zhu,H. Xue,R. Feng,C. Hu,S. Zhang,W. Zhang,Y. Zhao,X. Zeng,F. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/hbadoz
2021-01-01
Clinical and Experimental Rheumatology
Abstract:OBJECTIVSE To explore the clinical characteristics and treatment efficacy of IgG4-related disease (IgG4-RD) patients with different levels of serum IgG4. METHODS A total of 299 patients newly diagnosed with IgG4-RD were enrolled in this study. Patients were classified into four groups according to baseline serum IgG4 levels: Group A: normal concentration; Group B: > normal but <2× the upper reference limit (URL); Group C: between 2× and 5× the URL; Group D: >5× the URL. All patients were followed up for 12 months. The patients' clinical characteristics, laboratory parameters, plasmablasts/plasma cells and treatment efficacy were analysed. RESULTS IgG4-RD patients with higher serum IgG4 levels had higher percentages of dacryoadenitis, sialadenitis, and autoimmune pancreatitis and a higher prevalence of allergy history, whereas patients with retroperitoneum and mediastinum lesions usually had lower serum IgG4 levels. In addition, the serum IgG4 re-elevation rate in Group D (19.4%) was higher than those in Group B (4.9%) and Group C (7.7%) (p=0.003 and p=0.020, respectively). Patients suffered fewer clinical relapses with a serum IgG4 reduction ≥50% of baseline serum IgG4 in Group B and ≥40% of baseline serum IgG4 in Group D (p=0.019 and p=0.043, respectively). In addition, the rate of clinical relapse in patients who received combination therapy with glucocorticoids and mycophenolate mofetil was 18.75% in Group D, which was higher than the rates in Groups B and C (0) (p=0.027). CONCLUSIONS IgG4-RD patients with different levels of serum IgG4 exhibit different clinical characteristics and treatment responses.
What problem does this paper attempt to address?